KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $254.3 million.

  • Acadia Pharmaceuticals' Non-Current Assets rose 3487.31% to $254.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 5008.79%. This contributed to the annual value of $249.4 million for FY2024, which is 8778.6% up from last year.
  • Acadia Pharmaceuticals' Non-Current Assets amounted to $254.3 million in Q3 2025, which was up 3487.31% from $265.0 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Non-Current Assets registered a high of $265.0 million during Q2 2025, and its lowest value of $76.8 million during Q3 2021.
  • In the last 5 years, Acadia Pharmaceuticals' Non-Current Assets had a median value of $133.4 million in 2023 and averaged $147.1 million.
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Non-Current Assets surged by 25255.11% in 2021, and later tumbled by 294.54% in 2022.
  • Acadia Pharmaceuticals' Non-Current Assets (Quarter) stood at $82.3 million in 2021, then dropped by 2.95% to $79.9 million in 2022, then soared by 66.3% to $132.8 million in 2023, then surged by 87.79% to $249.4 million in 2024, then grew by 1.97% to $254.3 million in 2025.
  • Its Non-Current Assets stands at $254.3 million for Q3 2025, versus $265.0 million for Q2 2025 and $261.4 million for Q1 2025.